Polycystic ovary syndrome. Sclerocystic ovary syndrome
Conditions
Interventions
Intervention 1: Unilateral ovarian laparoscopic treatment in patients with polycystic ovary syndrome who resistant to drug treatment with a daily dose of 250 mg clomiphene citrate. Intervention 2: Th
Treatment - Surgery
Treatment - Drugs
Unilateral ovarian laparoscopic treatment in patients with polycystic ovary syndrome who resistant to drug treatment with a daily dose of 250 mg clomiphene citrate
The control group was clomiphene citrate administration with dose of 250 mg daily for 6 months in patients with polycystic ovary syndrome
Sponsors
Vise chanceller for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with polycystic ovary syndrome; PCOS patients resistance to drug clomiphene citrate; patients with symptoms of amenorrhea. Exclusion criteria: Patients with symptoms of oligomenorrhea; patients who were outside the age range.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum anti-mullerian levels. Timepoint: Pre-treatment and 1 week, 1 and 3 month after treatment. Method of measurement: Serum anti-mullerian hormon levels on nanomoles per mml. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ovarian response to treatment method. Timepoint: 1 and 3 month. Method of measurement: The first menstural cycle after treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Esmat Aghadavod Jolfaie
Kashan university of Medical sciences
Outcome results
None listed